|
⚲
|
| Keyboard |
| Paul Manning | |
|---|---|
| Firm | |
| Address | c/o Verrica Pharmaceuticals Inc 44 W Gay St, Suite 400 West Chester, PA 19380 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | 021-566413 | Director | 50.0 M of 50.0 M |
||
| Blue Marlin Therapeutics Inc | 021-561543 | Executive Officer | 0.1 M | ||
| Taysha Gene Therapies Inc | 021-463996 | Director | 30.0 M of 30.0 M |
||
| Xalud Therapeutics Inc | 021-401483 | Director | 18.2 M of 30.0 M |
||
| Liquidia Corp | 021-396169 | Director | 21.7 M of 21.7 M |
||
| Taysha Gene Therapies Inc | 021-373497 | Director | 96.0 M of 96.0 M |
||
| Taysha Gene Therapies Inc | 021-366194 | Director | 18.0 M of 30.0 M |
||
| Archerdx Inc | 021-366098 | Director | 1.6 M of 1.6 M |
||
| Xalud Therapeutics Inc | 021-363916 | Director | 5.0 M of 25.1 M |
||
| Archerdx Inc | 021-362094 | Director | 4.6 M of 4.6 M |
||
| Archerdx Inc | 021-362098 | Director | 1.3 M of 1.3 M |
||
| Tolerion Inc | 021-360181 | Director | 23.0 M of 29.8 M |
||
| Tolerion Inc | 021-359489 | Director | 20.0 M of 40.0 M |
||
| Archerdx Inc | 021-355639 | Director | 55.0 M of 55.0 M |
||
| Archerdx Inc | 021-340363 | Director | 15.0 M of 18.1 M |
||
| Advantagene Inc | 021-326482 | Director | 28.7 M of 28.7 M |
||
| Archerdx Inc | 021-308071 | Director | 37.6 M of 37.6 M |
||
| Verrica Pharmaceuticals Inc | 021-306127 | Director | 20.0 M of 21.0 M |
||
| Verrica Pharmaceuticals Inc | 021-301519 | Executive Officer | 5.0 M of 5.0 M |
||
| DOVA Pharmaceuticals Inc | 021-271207 | Executive Officer | 10.0 M of 40.0 M |
||
| Verrica Pharmaceuticals Inc | 021-253241 | Director | 2.4 M | ||
| Avexis Inc | 021-247819 | Director | 65.0 M of 65.0 M |
||
| Enzymatics Inc | 021-201385 | Director | 3.8 M of 3.8 M |
||
| GEN9 Inc | 021-178604 | Director | 0.4 M of 2.0 M |
||
| GEN9 Inc | 021-165572 | Director | 1.6 M of 9.6 M |
||